200HO11586 EINSTEIN

Print/PDF
Registration Name SILVERRIDGE V EINSTEIN-ET
Registration Number HOCAN000012857528
Primary NAAB Code 200HO11586
Secondary Code(s) 777HO11586, 517HO11586, 518HO11586, 722HO11586, 723HO11586
Status Active AI Sire
Controller Name Semex Alliance (200)
Date of Birth 4/18/2018
aAa 534126
DMS 345
GFI 12.9%
Genetic Codes * TD TY TL TV TR TP TC TE
Haplotypes HH1T, HH2C, HH3T, HH4T, HH5T, HH6T
Sire PROGENESIS TOPNOTCH-ET
MGS S-S-I MONTROSS DUKE-ET
Beta Casein A2A2
Kappa Casein AB
Beta Lactoglobulin -
INDEXES
NM$ 609, 92% R CM$ 639
NM Percentile 66% FM$ 544
GTPI 3209 GM$ 566
PRODUCTION TRAITS
6132 Dtrs 964 herds 42 % US 99% R
Milk 907 Fat, % 79 , +0.15%
SCS 2.7, 99% R Protein, % 44 , +0.05%
Feed Saved -319 , 58% R Milking Speed 6.86 , 94% R
Health & Fertility
Productive Life 3.5      98% R Mastitis 1.4      95% R
Heifer Livability -0.1       87% R Metritis 0.9      90% R
Livability 0.3      91% R D. Abom 0.0      94% R
DPR 0.1      98% R Ketosis 1.7      88% R
HCR 1.7      97% R R. Placenta 0.6      91% R
CCR 1.4      98% R Milk Fever -0.2      80% R
SCR 1.7      96% R
Calving Traits
Sire CE 1.5      99% R 7614 Obs
Daughter CE 1.6      97% R 1936 Obs, 2720 Dtrs
Sire SB 4.2      97% R 8550 Obs
Daughter SB 4.5      97% R 1893 Obs, Dtrs
Gestation Length -0.9      99% R 369 Obs, 5895 Dtrs
Early First Calving 2.6      96% R 252 Obs, 2265 Dtrs

CDCB December 2025; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 12/2025
2765 Dtrs 591 herds 99% R
PTA Type 0.61 UDC 1.15
FLC -0.49 BWC 1.09
Linear Traits
Stature -0.05
Short
Strength 0.97
Weak
Body Depth 0.53
Deep
Dairy Form -0.14
Closed
Rump Angle 0.16
Sloped
Thurl Width 1.72
Wide
Rear Legs-Side View -1.74
Straight
Rear Legs-Rear View -0.94
H.-in
Foot Angle 0.03
Steep
Feet & Legs Score -0.28
Low
F.U. Attachment 0.15
Strong
Rear Udder Height 1.08
High
Rear Udder Width 2.56
Wide
Udder Cleft 1.93
Strong
Udder Depth 0.12
Shallow
Front Teat Placement 1.06
Close
Rear Teat Placement 1.61
Close
Teat Length 0.70
Long
-2
0
2

CDCB December 2025; Base of Evaluation: HO